Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/07/2026
Greenwich Life Sciences announces that its mass-produced GP2 has been approved by the EU for use in the FLAMINGO-01 clinical trial.
Latest
2 m ago
PointHub (02586.HK) spent 3.0854 million Hong Kong dollars to repurchase 50.67 thousand shares on July 9th.
3 m ago
According to Jordanian media reports on the 9th, sirens were heard in many parts of Jordan.
3 m ago
There was an explosion at the Ali Salim Air Base and Kuwait Port area.
4 m ago
Mu Xi co-founder Peng Li: Domestic AI companies and products are still far from enough. Computing power, storage, and connectivity need to find a balance.
4 m ago
McKo Pharmaceuticals-B (02335.HK): The Phase II clinical trial of MT1002 for anticoagulation in hemodialysis patients has completed the enrollment of the first patient.
See all latest
